Mar 26, 2018 11:35 am UTC| Business
NEW YORK, March 26, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Klondex Mines...
Global Cancer Vaccine Partnering Directory 2012-2018: Deal Trends, Players, Financials and Forecasts
Mar 26, 2018 11:32 am UTC| Business
Dublin, March 26, 2018 -- The "Global Cancer Vaccine Partnering 2012-2018: Deal trends, players, financials and forecasts" report has been added to ResearchAndMarkets.com's offering. The Global...
TG Therapeutics, Inc. to Present at the Needham 17th Annual Healthcare Conference
Mar 26, 2018 11:30 am UTC| Business
NEW YORK, March 26, 2018 -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will present at the Needham 17th Annual Healthcare...
Mar 26, 2018 11:30 am UTC| Business
NEW YORK, March 26, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ShotSpotter Inc....
Monro, Inc. Appoints Evan Naylor as Chief Operating Officer
Mar 26, 2018 11:30 am UTC| Business
ROCHESTER, N.Y., March 26, 2018 -- Monro, Inc. (Nasdaq:MNRO), a leading provider of automotive undercar repair and tire services, today announced that Evan Naylor has been appointed to the position of Chief Operating...
Strongbridge Biopharma plc to Host Investor and Analyst Day on April 5, 2018
Mar 26, 2018 11:30 am UTC| Business
DUBLIN, Ireland and TREVOSE, Pa., March 26, 2018 -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare...
Cancer Genetics to Host Fourth Quarter and Full Year 2017 Financial Results
Mar 26, 2018 11:30 am UTC| Business
RUTHERFORD, N.J., March 26, 2018 -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that it will release its financial...